• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication during breastfeeding and pregnancy is challenging for women with the condition. There aren't enough data regarding how to get adhd meds without diagnosis exposure over time may affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are required.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the benefits of using them against the risks to the foetus. Physicians don't have the data to give clear advice but they can provide information about risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who took ADHD medications used for adhd in early pregnancy did not have a significantly higher risk of fetal cardiac malformations or major structural birth defects. Researchers used a large sample-based case control study to examine the prevalence of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts reviewed the cases in order to ensure that the classification was correct and to reduce any bias.

The study conducted by the researchers was not without limitations. The researchers were not able, in the first place, to separate the effects triggered by the medication from the disorder. That limitation makes it difficult to know whether the small differences observed in the exposed groups are due to the use of medication or comorbidities that cause confusion. In addition the study did not examine the long-term effects of offspring on their parents.

The study found that infants whose mother had taken ADHD medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU), compared to mothers who did not take any medication during pregnancy, or had stopped taking their medication before or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who took stimulant ADHD medication during pregnancy were also at an increased chance of having a caesarean birth or having a child with an low Apgar score (less than 7). These increases appear to be independent of the type of medication used during pregnancy.

Researchers suggest that the minor risk of using best adhd medication for adults medications during early pregnancies could be offset by the more beneficial outcomes for both baby and mother of continued treatment for the woman's condition. Physicians should speak with their patients about this issue and as much as possible, assist them improve coping skills which may reduce the effects of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and being treated with medication, the issue of whether to continue or stop treatment during pregnancy is a question that more and more doctors have to face. Most of the time, these decisions are made in the absence of any evidence that is clear and definitive in either case, which means that doctors must weigh their knowledge about their experiences, the experiences of other doctors, and what research suggests on the subject as well as their own judgments for each individual patient.

In particular, the issue of potential risks to the infant can be difficult. The research on this subject is based on observation rather than controlled studies, and the results are conflicting. The majority of studies limit their analysis to live births, which can underestimate the teratogenic impact leading to abortions or terminations of pregnancy. The study that is discussed in this journal club addresses these shortcomings by analyzing data on live and deceased births.

The conclusion: While some studies have shown an association between ADHD medications and the risk of certain birth defects, other studies have found no such relationship and the majority of studies demonstrate a neutral or slightly negative effect. In every case an in-depth evaluation of the benefits and risks is required.

For women suffering from ADHD and ADD, the decision to discontinue medication can be difficult, if not impossible. In fact, in an article recently published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of isolation, and family conflict for these patients. In addition, a decrease in medication may affect the ability to do work-related tasks and safely drive that are crucial aspects of daily life for many people suffering from ADHD.

She suggests women who are unsure about whether to keep or stop taking medication because of their pregnancy should consider informing family members, friends and colleagues on the condition, its impact on daily life, and the advantages of continuing the current treatment plan. It can also aid in ensuring that the woman feels supported when she is struggling with her decision. It is important to remember that some drugs can my general practitioner prescribe adhd medication pass through the placenta, so if a woman decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the medication could be transferred to the child.

Birth Defects Risk

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows there are concerns about what impact the medications could have on fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing information on this topic. Utilizing two huge data sets, researchers were able to examine more than 4.3 million pregnancies to determine whether stimulant medication use increased the risk of birth defects. Researchers discovered that although the risk overall is low, the first trimester ADHD exposure to medication was associated with slightly higher rates of specific heart defects like ventriculoseptal defect.

The researchers of the study didn't discover any connection between early medication usage and other congenital anomalies like facial deformities or club feet. The results are consistent with previous studies revealing an increase, but not significant, in the risk of cardiac malformations among women who began taking ADHD medications before the time of pregnancy. This risk increased during the latter part of pregnancy, as many women are forced to stop taking their ADHD medication.

Women who took ADHD medications during the first trimester of pregnancy were also more likely to experience caesarean sections, a low Apgar score after delivery and a baby that required breathing assistance during birth. The authors of the study were unable to remove bias in selection since they limited their study to women with no other medical conditions that could have contributed to the findings.

Researchers hope that their research will provide doctors with information when they see pregnant women. They advise that while the discussion of the benefits and risks is important but the decision to stop or continue medication should be based on the woman's requirements and the severity of her ADHD symptoms.

The authors warn that, while stopping the medication is a possibility to think about, it isn't recommended due to the high rate depression and other mental problems in women who are expecting or recently gave birth. Further, research shows that women who stop taking their medication will have a harder transitioning to life without them after the baby is born.

Nursing

It can be overwhelming becoming a mother. Women who suffer from ADHD who must work through their symptoms while attending doctor appointments, getting ready for the arrival of a baby and adjusting to new household routines can experience severe challenges. Therefore, many women elect to continue taking their ADHD medications used to treat adhd throughout the course of pregnancy.

The risk to a breastfeeding infant is minimal because the majority of stimulant medication passes through breast milk at low levels. However, the amount of medication exposure to the newborn can vary depending on dosage, frequency it is taken and the time of the day the medication is administered. In addition, different medications are introduced into the baby's system via the gastrointestinal tract or through breast milk. The impact on the health of a newborn isn't completely known.

Because of the lack of research, some doctors may be inclined to discontinue stimulant medications during the pregnancy of a woman. This is a difficult decision for the patient, who must balance the benefits of keeping her medication against the potential risks to the embryo. Until more information is available, GPs should ask all pregnant patients about their history of ADHD and if they are taking or planning to take medication during the perinatal time.

A increasing number of studies have shown that the majority of women are able to safely continue to take their ADHD medication during pregnancy and while breastfeeding. In response, an increasing number of patients are choosing to continue their medication. They have concluded, in consultation with their doctors that the benefits of continuing their current medication outweigh any risk.

Women with ADHD who are planning to breastfeed should seek advice from an expert psychiatrist prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continuing treatment, including non stimulant adhd medications for Adults-pharmacological management strategies. Psychoeducation is also required to help pregnant women suffering from ADHD understand their symptoms and the underlying disorder and learn about treatments and to reinforce existing coping strategies. This should be a multidisciplinary process together with obstetricians, GPs, and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, monitoring of signs of deterioration and, if needed, adjustments to the medication regimen.